Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$358K Sell
2,729
-395
-13% -$60K 0.32% 51
2023
Q2
$497K Sell
3,124
-269
-8% -$43.4K 0.4% 32
2023
Q1
$537K Sell
3,393
-58
-2% -$8.7K 0.41% 27
2022
Q4
$484K Sell
3,451
-235
-6% -$33.4K 0.4% 37
2022
Q3
$473K Sell
3,686
-214
-5% -$30.9K 0.4% 36
2022
Q2
$550K Buy
3,900
+152
+4% +$21.7K 0.46% 14
2022
Q1
$521K Buy
3,748
+471
+14% +$72.2K 0.44% 24
2021
Q4
$571K Buy
+3,277
New +$546K 0.42% 26

Other funds holding CLX

Syntax Advisors's CLX Position: Q3 2023 in Review

Syntax Advisors reduced its Clorox (CLX) stake by 13% in Q3 2023, selling an estimated $60K and leaving 2,729 shares worth $358K. The position accounts for 0.32% of the portfolio, ranked #51.

Syntax Advisors first reported a position in CLX in Q4 2021 and has held it in 8 quarters since. The position peaked at $571K in Q4 2021. 1,064 funds tracked by Wall St. Rank hold CLX as of Q3 2023.

  • Syntax Advisors held 2,729 shares of Clorox worth $358K as of Q3 2023.
  • Syntax Advisors sold 395 Clorox shares in Q3 2023, an estimated $60K.
  • Clorox made up 0.32% of Syntax Advisors's portfolio in Q3 2023, its #51 holding.
  • Syntax Advisors first reported a position in Clorox in Q4 2021 and has held it in 8 quarters since.
  • Syntax Advisors's Clorox position peaked at $571K in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Clorox as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.